Prof. Umberto Tirelli - Pubblicazioni

Genome wide DNA-profiling of HIV-related B-cell lymphomas.
Br J Haematol. 2009 Oct 12.
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Lancet Oncol. 2009 Oct 12.
Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective.
Ann Oncol. 2009 Aug;20(8):1445.
Comment on: Ann Oncol. 2009 Mar;20(3):403-12.
High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long term results of the GICAT study with analysis of prognostic factors.
Blood. 2009 May 18.
Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature.
Hum Pathol. 2009 May 6.
Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
J Med Virol. 2009 May;81(5):888-96.
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas
Br J Haematol. 2009 Feb 12.
Cancer in the elderly: The caregivers' perception of senior patients' informational needs.
Arch Gerontol Geriatr. 2008 Dec 11.
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
AIDS. 2008 Oct 18;22(16):2143-53.
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience.
Br J Cancer. 2008 Sep 9.
FOSFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients.
J Chemother. 2008 Aug;20(4):503-8.
Cancer survivorship: a challenge for the European oncologists.
Ann Oncol. 2008 Jun 4
Clinical management of long-term cancer survivors.
J Clin Oncol. 2008 Jan 1;26(1):161-2
MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients.
Int J Biol Markers. 2007 Oct-Dec;22(4):307-11.
Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study.
Lung Cancer. 2007 Nov 16
The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma.
Int J Cancer. 2007 Dec 4
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
N Engl J Med. 2007 Nov 8;357(19):1916-27
Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.
Clin Exp Immunol. 2007 Oct 11
Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
Lung Cancer. 2006 Oct 23
Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma.
Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1168-77
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
J Clin Oncol. 2006 Jul 1;24(19):3128-35
Treatment of elderly cancer patients: a planet in evolution.
J Am Geriatr Soc. 2006 Feb;54(2):372-3
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
J Clin Oncol. 2006 Feb 1;24(4):681-7
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy.
Blood. 2006 May 15;107(10):3832-40
Keynote comment: reimbursement for molecularly targeted anticancer agents.
Lancet Oncol. 2006 Jan;7(1):2-3.
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
Ann Oncol. 2006 Mar;17(3):533.
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.
Clin Lymphoma Myeloma. 2005 Sep;6(2):122-30.
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
J Clin Oncol. 2005 Oct 1;23(28):6865-72.
Gefitinib in patients with non-small cell lung cancer: symptomatic improvement within a few days.
Lung Cancer. 2005 Sep;49(3):417-8.
Cancer and aging: are there any differences in the information needs of elderly and younger patients? Results from an Italian observational study.
Ann Oncol. 2005 Dec;16(12):1982-3.
Cancer Prevention and Early Diagnosis in HIV-Positive Individuals.
J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):628-9.
Treatment of head and neck cancer in elderly patients: state of the art and guidelines.
Crit Rev Oncol Hematol. 2005 Jan;53(1):71-80
Rituximab plus infusional cyclophosphamide, doxorubicin and etoposide (R-CDE) in HIV-associated non-Hodgkin's lymphoma: pooled results from three phase II trials.
Blood. 2005 Mar 1;105(5):1891-7.
Fatigue in cancer patients receiving chemotherapy: analysis of published studies.
Ann Oncol. 2004 Oct;15(10):1576
Rituximab-CHOP or 2 weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
Ann Oncol. 2004 Aug;15(8):1298
Improving information to Italian cancer patients: results of a randomized study.
Ann Oncol. 2004 May;15(5):721-5.
Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi's sarcoma.
High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single institution study.
AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the HAART era - the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive from Antiretrovirals.
J Clin Oncol. 2003 Aug 1;21(15):2876-82.
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
N Engl J Med. 2003 Jun 12;348(24):2396-406.
Comprehensive geriatric evaluation in elderly patients with lymphoma: feasibility of a patient-tailored treatment plan.
J Clin Oncol. 2003 Feb 15;21(4):754
Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type.
Cancer Immunol Immunother. 2003 Jan;52(1):28-32.
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Sindrome Study Group.
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC Study.
A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute.
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
AIDS. 2000 Jul 7;14(10):1457-8.
Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy
AIDS. 2000 Aug 18;14(12):1675-88
Immunological abnormalities in patients with chronic fatigue syndrome.
Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data.
Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
Invasive cervical cancer after treatment for cervical intraepithelial neoplasia.
Lung carcinoma in 36 patients with human immunodeficiency virus infection.
Debate on Di Bella therapy.
Lung cancer in the elderly.
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective.
Non Hodgkin's lymphoma in the elderly.
A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate-and high-grade lymphoma.
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.
Cancer in the elderly: why so badly treated?